SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-049453
Filing Date
2020-11-02
Accepted
2020-11-02 08:45:12
Documents
7
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20201102.htm 6-K 38047
2 EX-99.1 lmnl-ex991_13.htm EX-99.1 286261
3 EX-99.2 lmnl-ex992_11.htm EX-99.2 213662
4 EX-99.3 lmnl-ex993_12.htm EX-99.3 142885
5 EX-99.4 lmnl-ex994_10.htm EX-99.4 25835
6 EX-99.5 lmnl-ex995_9.htm EX-99.5 16126
7 GRAPHIC gkjboxkywh0l000001.jpg GRAPHIC 8584
  Complete submission text file 0001564590-20-049453.txt   735927
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 201279083
SIC: 2834 Pharmaceutical Preparations